Substituted pyrrolo-pyrazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful in therapy in the treatment of diseases associated with dysregulated protein kinase activity, like cancer.
本发明揭示了公式(I)的取代
吡咯-
吡唑衍
生物及其药学上可接受的盐,其定义在规范中,以及制备它们的过程和包含它们的制药组合物; 本发明中的化合物可能在治疗与蛋白激酶活性失调相关的疾病,如癌症方面有用。